Pub Date : 2015-11-01DOI: 10.1177/0091217415612734
J. Aikens, M. Klinkman, Ananda Sen, D. Nease
Objective The Remission Evaluation and Mood Inventory Tool (REMIT) is a practical 5-item self-report measure of key positive mood states associated with recovering from depression, as distinct from depressive symptoms per se. The study goal was to identify a clinically useful threshold for interpreting REMIT responses in the context of mild to moderate depressive symptoms. Methods This was a secondary analysis of a cross-sectional dataset initially used to develop and validate the REMIT. Primary care patients being treated for depressive symptoms of either mild or moderate severity (n = 247 and 240, respectively) rated their perceived degree of depression remission prior to completing the Patient Health Questionnaire-8 (PHQ-8) and the REMIT. We summed the totals of the latter two measures to form the PHQ + REMIT index. Results Receiver Operating Characteristics analysis indicated that the PHQ + REMIT threshold ≥13 was associated with good sensitivity (92%) and acceptable specificity (43%) to the absence of patient-perceived remission. In contrast, the PHQ had only 21% specificity at this sensitivity level. Area under the curve was 0.815 (95% C.I.: 0.765–0.865), which was significantly greater than that of the PHQ-8 alone (area under the curve = 0.745, 95% C.I.: 0.691–0.805, p(diff) = 0.0002). Threshold performance was unaffected by adjustment for demographic characteristics and variation in remission percentage. Compared with standard symptom-based classification, using the REMIT reclassified 27% of mildly symptomatic patients as remitted. Conclusions Using the REMIT with patients who have mild to moderate depressive symptoms improves the assessment of patient-perceived remission, which is indicated by a summed PHQ + REMIT index of less than 13. Longitudinal research is needed to test whether this broadened patient-centered approach to assessing remission improves clinical decision making and long-term outcomes.
{"title":"Improving the assessment of depression remission with the Remission Evaluation and Mood Inventory Tool","authors":"J. Aikens, M. Klinkman, Ananda Sen, D. Nease","doi":"10.1177/0091217415612734","DOIUrl":"https://doi.org/10.1177/0091217415612734","url":null,"abstract":"Objective The Remission Evaluation and Mood Inventory Tool (REMIT) is a practical 5-item self-report measure of key positive mood states associated with recovering from depression, as distinct from depressive symptoms per se. The study goal was to identify a clinically useful threshold for interpreting REMIT responses in the context of mild to moderate depressive symptoms. Methods This was a secondary analysis of a cross-sectional dataset initially used to develop and validate the REMIT. Primary care patients being treated for depressive symptoms of either mild or moderate severity (n = 247 and 240, respectively) rated their perceived degree of depression remission prior to completing the Patient Health Questionnaire-8 (PHQ-8) and the REMIT. We summed the totals of the latter two measures to form the PHQ + REMIT index. Results Receiver Operating Characteristics analysis indicated that the PHQ + REMIT threshold ≥13 was associated with good sensitivity (92%) and acceptable specificity (43%) to the absence of patient-perceived remission. In contrast, the PHQ had only 21% specificity at this sensitivity level. Area under the curve was 0.815 (95% C.I.: 0.765–0.865), which was significantly greater than that of the PHQ-8 alone (area under the curve = 0.745, 95% C.I.: 0.691–0.805, p(diff) = 0.0002). Threshold performance was unaffected by adjustment for demographic characteristics and variation in remission percentage. Compared with standard symptom-based classification, using the REMIT reclassified 27% of mildly symptomatic patients as remitted. Conclusions Using the REMIT with patients who have mild to moderate depressive symptoms improves the assessment of patient-perceived remission, which is indicated by a summed PHQ + REMIT index of less than 13. Longitudinal research is needed to test whether this broadened patient-centered approach to assessing remission improves clinical decision making and long-term outcomes.","PeriodicalId":22510,"journal":{"name":"The International Journal of Psychiatry in Medicine","volume":"91 1","pages":"383 - 397"},"PeriodicalIF":0.0,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83023153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-11-01DOI: 10.1177/0091217415612701
A. Gritti, S. Pisano, G. Catone, R. Iuliano, T. Salvati, Paolo Gritti
The cooccurrence of Marfan syndrome and psychiatric disorders has been reported for many years. Furthermore, neuropsychological deficits have been shown to be associated with Marfan syndrome. The aim of the present article is to summarize findings from the sparse studies and case reports available. The results hold clinical and therapeutic implications and suggest that psychological and neuropsychological domains in Marfan syndrome patients should be carefully assessed. In particular, some patients may require specific rehabilitation programs. On this basis, a multidisciplinary approach to Marfan syndrome treatment seems mandatory.
{"title":"Psychiatric and neuropsychological issues in Marfan syndrome","authors":"A. Gritti, S. Pisano, G. Catone, R. Iuliano, T. Salvati, Paolo Gritti","doi":"10.1177/0091217415612701","DOIUrl":"https://doi.org/10.1177/0091217415612701","url":null,"abstract":"The cooccurrence of Marfan syndrome and psychiatric disorders has been reported for many years. Furthermore, neuropsychological deficits have been shown to be associated with Marfan syndrome. The aim of the present article is to summarize findings from the sparse studies and case reports available. The results hold clinical and therapeutic implications and suggest that psychological and neuropsychological domains in Marfan syndrome patients should be carefully assessed. In particular, some patients may require specific rehabilitation programs. On this basis, a multidisciplinary approach to Marfan syndrome treatment seems mandatory.","PeriodicalId":22510,"journal":{"name":"The International Journal of Psychiatry in Medicine","volume":"3 1","pages":"347 - 360"},"PeriodicalIF":0.0,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87877042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-11-01DOI: 10.1177/0091217415612735
M. Gable, D. Depry
Objective Corticosteroids generally result in short-lasting neuropsychiatric symptoms following cessation, but the following case highlights an unusually long-lasting course of symptoms in a patient following near immediate cessation of medication, despite medication management and electroconvulsive therapy. The case presentation will be followed by a discussion of the presentation, treatment, and management of steroid-induced neuropsychiatric symptoms. Methods The patient was followed from symptom onset to resolution. Results The patient’s symptom course was unusually long and required a long course of multimodal therapy. Conclusions Corticosteroids are commonly used medications both in a wide variety of medical settings, and despite this, their neuropsychiatric effects are poorly understood. The affective and behavioral symptoms, in particular mania and psychosis, can be unpredictable and challenging to treat as in our patient, who developed a long-lasting psychotic episode on high-dose steroids despite discontinuation and treatment of nearly six months. This was despite having tolerated steroids multiple times in the past.
{"title":"Sustained corticosteroid- induced mania and psychosis despite cessation","authors":"M. Gable, D. Depry","doi":"10.1177/0091217415612735","DOIUrl":"https://doi.org/10.1177/0091217415612735","url":null,"abstract":"Objective Corticosteroids generally result in short-lasting neuropsychiatric symptoms following cessation, but the following case highlights an unusually long-lasting course of symptoms in a patient following near immediate cessation of medication, despite medication management and electroconvulsive therapy. The case presentation will be followed by a discussion of the presentation, treatment, and management of steroid-induced neuropsychiatric symptoms. Methods The patient was followed from symptom onset to resolution. Results The patient’s symptom course was unusually long and required a long course of multimodal therapy. Conclusions Corticosteroids are commonly used medications both in a wide variety of medical settings, and despite this, their neuropsychiatric effects are poorly understood. The affective and behavioral symptoms, in particular mania and psychosis, can be unpredictable and challenging to treat as in our patient, who developed a long-lasting psychotic episode on high-dose steroids despite discontinuation and treatment of nearly six months. This was despite having tolerated steroids multiple times in the past.","PeriodicalId":22510,"journal":{"name":"The International Journal of Psychiatry in Medicine","volume":"37 1","pages":"398 - 404"},"PeriodicalIF":0.0,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85140743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-11-01DOI: 10.1177/0091217415612736
B. J. Matthew, Joanna S Gedzior
This report attempts to highlight that use of an antipsychotic and concurrent chronic use of methamphetamine can cause drug-induced parkinsonism. Methamphetamine is usually not encountered in the list of agents that induce drug-induced parkinsonism and so its consideration particularly during chronic use by a patient who is also on an antipsychotic is worthwhile because of its popularity as an illegal narcotic. This case report describes just such a case of drug-induced parkinsonism which is a subacute syndrome that mimics Parkinson’s disease. Although less alarming than dystonia, it is more common, more difficult to treat and can be the cause of significant disability during maintenance treatment especially in the elderly. In most cases, symptoms are reversible in days or weeks, but occasionally, especially in the elderly, or if long-acting injectable antipsychotics are used—as in this case—symptoms may last for weeks or months. The report also illustrates the neuronal workings due to chronic methamphetamine-use and the additive effects of dopamine blockade by antipsychotics such as haloperidol.
{"title":"Drug-induced parkinsonism following chronic methamphetamine use by a patient on haloperidol decanoate","authors":"B. J. Matthew, Joanna S Gedzior","doi":"10.1177/0091217415612736","DOIUrl":"https://doi.org/10.1177/0091217415612736","url":null,"abstract":"This report attempts to highlight that use of an antipsychotic and concurrent chronic use of methamphetamine can cause drug-induced parkinsonism. Methamphetamine is usually not encountered in the list of agents that induce drug-induced parkinsonism and so its consideration particularly during chronic use by a patient who is also on an antipsychotic is worthwhile because of its popularity as an illegal narcotic. This case report describes just such a case of drug-induced parkinsonism which is a subacute syndrome that mimics Parkinson’s disease. Although less alarming than dystonia, it is more common, more difficult to treat and can be the cause of significant disability during maintenance treatment especially in the elderly. In most cases, symptoms are reversible in days or weeks, but occasionally, especially in the elderly, or if long-acting injectable antipsychotics are used—as in this case—symptoms may last for weeks or months. The report also illustrates the neuronal workings due to chronic methamphetamine-use and the additive effects of dopamine blockade by antipsychotics such as haloperidol.","PeriodicalId":22510,"journal":{"name":"The International Journal of Psychiatry in Medicine","volume":"31 1","pages":"405 - 411"},"PeriodicalIF":0.0,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77607150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-10-01DOI: 10.1177/0091217415610306
Lin Zhang, Wenjing Dong, Jie Han, Zhe Wang, Dayong Sun, Xiaofei Ji, Ming Li, B. Zhang
Background Chronic cerebral circulation insufficiency (CCCI) refers to cerebral dysfunctions that lead to cerebral vascular pathological changes. Our aim is to identify factors related to cognitive impairment in CCCI. Methods CCCI patients (n = 102) were assessed with the Montreal cognitive assessment (MoCA) to analyze cognitive impairment. Patients were divided into two groups according to MoCA scores: (1) cognitive dysfunction and (2) normal cognitive function. We compared the clinical information with univariate and multivariate logistic regression analyses and identified major risk factors related to cognitive impairment in CCCI. Results Age (p = 0.007, OR = 3.768, χ2 = 7.173), leukoaraiosis (p = 0.002, OR = 6.231, χ2 = 9.478), a history of hypertension (p = 0.021, OR = 3.078, χ2 = 5.307), a history of hyperlipidemia (p = 0.016, OR = 3.429, χ2 = 5.795), and the number of vascular risk factors (p = 0.019, χ2 = 9.921) were related to cognitive impairment by univariate analysis. Age (p = 0.070, OR = 2.689, 95% CI = 0.923 ± 7.837) and leukoaraiosis (p = 0.012, OR = 4.531, 95% CI = 1.401 ± 14.667) were significant by multivariate logistic regression analysis. Age (r = −0.585, p < 0.01) had a marked negative correlation with MoCA scores. There were significant differences in the MoCA subscale scores, including visuospatial and executive capacity (p < 0.01), attention and calculation (p < 0.01), and delayed recall (p < 0.01), in patients with different degrees of leukoaraiosis. Patients with CCCI had a higher incidence of cognitive impairment (78.4%). Conclusions Changes in visuospatial and executive capacity, delayed recall, and language function represent cognitive manifestations in CCCI. Age and leukoaraiosis have the strongest effects on cognitive impairment morbidity and can aggravate cognitive impairment.
背景慢性脑循环不全(CCCI)是指导致脑血管病变的脑功能障碍。我们的目的是确定CCCI中与认知障碍相关的因素。方法对102例CCCI患者进行蒙特利尔认知评估(MoCA)，分析认知功能障碍。根据MoCA评分将患者分为两组:(1)认知功能障碍组和(2)认知功能正常组。我们将临床信息与单变量和多变量logistic回归分析进行比较，确定了CCCI中与认知功能障碍相关的主要危险因素。结果单因素分析显示，年龄(p = 0.007, OR = 3.768， χ2 = 7.173)、白质变(p = 0.002, OR = 6.231， χ2 = 9.478)、高血压史(p = 0.021, OR = 3.078， χ2 = 5.307)、高脂血症史(p = 0.016, OR = 3.429， χ2 = 5.795)、血管危险因素数量(p = 0.019， χ2 = 9.921)与认知功能障碍相关。多因素logistic回归分析显示，年龄(p = 0.070, OR = 2.689, 95% CI = 0.923±7.837)、白质病变(p = 0.012, OR = 4.531, 95% CI = 1.401±14.667)具有显著性差异。年龄与MoCA评分呈显著负相关(r = - 0.585, p < 0.01)。不同程度白质病变患者的MoCA亚量表得分，包括视觉空间和执行能力(p < 0.01)、注意和计算能力(p < 0.01)、延迟回忆能力(p < 0.01)，差异均有统计学意义。CCCI患者认知功能障碍发生率较高(78.4%)。结论视觉空间和执行能力、延迟回忆和语言功能的改变是CCCI的认知表现。年龄和白质病变对认知障碍发病率的影响最大，并可加重认知障碍。
{"title":"Montreal cognitive assessment and analysis of related factors for cognitive impairment in patients with chronic cerebral circulation insufficiency","authors":"Lin Zhang, Wenjing Dong, Jie Han, Zhe Wang, Dayong Sun, Xiaofei Ji, Ming Li, B. Zhang","doi":"10.1177/0091217415610306","DOIUrl":"https://doi.org/10.1177/0091217415610306","url":null,"abstract":"Background Chronic cerebral circulation insufficiency (CCCI) refers to cerebral dysfunctions that lead to cerebral vascular pathological changes. Our aim is to identify factors related to cognitive impairment in CCCI. Methods CCCI patients (n = 102) were assessed with the Montreal cognitive assessment (MoCA) to analyze cognitive impairment. Patients were divided into two groups according to MoCA scores: (1) cognitive dysfunction and (2) normal cognitive function. We compared the clinical information with univariate and multivariate logistic regression analyses and identified major risk factors related to cognitive impairment in CCCI. Results Age (p = 0.007, OR = 3.768, χ2 = 7.173), leukoaraiosis (p = 0.002, OR = 6.231, χ2 = 9.478), a history of hypertension (p = 0.021, OR = 3.078, χ2 = 5.307), a history of hyperlipidemia (p = 0.016, OR = 3.429, χ2 = 5.795), and the number of vascular risk factors (p = 0.019, χ2 = 9.921) were related to cognitive impairment by univariate analysis. Age (p = 0.070, OR = 2.689, 95% CI = 0.923 ± 7.837) and leukoaraiosis (p = 0.012, OR = 4.531, 95% CI = 1.401 ± 14.667) were significant by multivariate logistic regression analysis. Age (r = −0.585, p < 0.01) had a marked negative correlation with MoCA scores. There were significant differences in the MoCA subscale scores, including visuospatial and executive capacity (p < 0.01), attention and calculation (p < 0.01), and delayed recall (p < 0.01), in patients with different degrees of leukoaraiosis. Patients with CCCI had a higher incidence of cognitive impairment (78.4%). Conclusions Changes in visuospatial and executive capacity, delayed recall, and language function represent cognitive manifestations in CCCI. Age and leukoaraiosis have the strongest effects on cognitive impairment morbidity and can aggravate cognitive impairment.","PeriodicalId":22510,"journal":{"name":"The International Journal of Psychiatry in Medicine","volume":"1 1","pages":"257 - 270"},"PeriodicalIF":0.0,"publicationDate":"2015-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83586076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-10-01DOI: 10.1177/0091217415610320
A. Landa, Natalia A Skritskaya, Andel V Nicasio, J. Humensky, R. Lewis-Fernández
The stress of immigration can increase risk for major depressive disorder (MDD), while cultural factors can contribute to difficulty in diagnosis and treatment of MDD among immigrant populations. Consequently, immigrants are less likely to have their treatment needs met. Our goal was to assess the unmet need for the diagnosis and treatment of depression among immigrants from the former USSR—a large immigrant group in the US—as well as demographic characteristics and immigration history associated with depression. We conducted a survey in an urban primary care clinic using measures of MDD symptoms (Patient Health Questionnaire-9), functioning, and treatment history among 102 Russian-speaking immigrants. Current moderate-to-severe symptoms of MDD were reported by 26.5% of participants with 33.3% of the symptomatic patients reporting suicidal ideation. Among participants with probable MDD, 63.0% reported not receiving mental health treatment and 59.3% never being diagnosed with MDD. The rates of untreated depression did not vary by gender nor did they diminish with prolonged stay in the US. Results suggest that undiagnosed and untreated depression is highly prevalent in this immigrant group.
{"title":"Unmet need for treatment of depression among immigrants from the former USSR in the US: A primary care study","authors":"A. Landa, Natalia A Skritskaya, Andel V Nicasio, J. Humensky, R. Lewis-Fernández","doi":"10.1177/0091217415610320","DOIUrl":"https://doi.org/10.1177/0091217415610320","url":null,"abstract":"The stress of immigration can increase risk for major depressive disorder (MDD), while cultural factors can contribute to difficulty in diagnosis and treatment of MDD among immigrant populations. Consequently, immigrants are less likely to have their treatment needs met. Our goal was to assess the unmet need for the diagnosis and treatment of depression among immigrants from the former USSR—a large immigrant group in the US—as well as demographic characteristics and immigration history associated with depression. We conducted a survey in an urban primary care clinic using measures of MDD symptoms (Patient Health Questionnaire-9), functioning, and treatment history among 102 Russian-speaking immigrants. Current moderate-to-severe symptoms of MDD were reported by 26.5% of participants with 33.3% of the symptomatic patients reporting suicidal ideation. Among participants with probable MDD, 63.0% reported not receiving mental health treatment and 59.3% never being diagnosed with MDD. The rates of untreated depression did not vary by gender nor did they diminish with prolonged stay in the US. Results suggest that undiagnosed and untreated depression is highly prevalent in this immigrant group.","PeriodicalId":22510,"journal":{"name":"The International Journal of Psychiatry in Medicine","volume":"49 1","pages":"271 - 289"},"PeriodicalIF":0.0,"publicationDate":"2015-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76400608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-10-01DOI: 10.1177/0091217415610310
C. Othieno, R. Okoth, K. Peltzer, S. Pengpid, Lucas Malla
Objective To describe the prevalence and types of injuries in relation to traumatic experiences, posttraumatic stress symptoms, depression, and health-risk behaviors among university students in Kenya. Method A cross-sectional study collected data on a random sample of university students using a questionnaire to record sociodemographic variables while injuries experiences recorded using the Centers for Disease control criteria and Breslau’s seven-item screener was used to identify post-traumatic stress disorder (PTSD) symptoms. Depressive symptoms were measured using Center for Epidemiological Studies Short Depression Scale. Results Nine hundred and twenty-three students (525 male and 365 female) were included in the study, mean age 23 years (SD 4.0). Serious injury in the previous 12 months was reported by 29.00% of the students. PTSD was present in 15.67% (men 15.39% and women 16.1%). Out of the total, 41.33% of the students had depressive symptoms (35.71% mild–moderate symptoms and 5.62% severe). In the multivariable logistic regression being poor, binge drinking, tobacco use, ever been diagnosed with HIV, physically abused as a child, high PTSD score, and depression (adjusted odds ratio 5.49, 95% confidence interval 4.32–13.21) were significantly (p value < 5%) associated with injury in the last 12 months. Conclusion Unintentional injuries and PTSD symptoms are common in this student population and are positively linked to depression and other risky behaviors. Measures aimed at improving the mental health, such as early identification and treatment of depression, may be useful in reducing the prevalence of such injuries among the youth.
{"title":"Traumatic experiences, posttraumatic stress symptoms, depression, and health-risk behavior in relation to injury among University of Nairobi students in Kenya","authors":"C. Othieno, R. Okoth, K. Peltzer, S. Pengpid, Lucas Malla","doi":"10.1177/0091217415610310","DOIUrl":"https://doi.org/10.1177/0091217415610310","url":null,"abstract":"Objective To describe the prevalence and types of injuries in relation to traumatic experiences, posttraumatic stress symptoms, depression, and health-risk behaviors among university students in Kenya. Method A cross-sectional study collected data on a random sample of university students using a questionnaire to record sociodemographic variables while injuries experiences recorded using the Centers for Disease control criteria and Breslau’s seven-item screener was used to identify post-traumatic stress disorder (PTSD) symptoms. Depressive symptoms were measured using Center for Epidemiological Studies Short Depression Scale. Results Nine hundred and twenty-three students (525 male and 365 female) were included in the study, mean age 23 years (SD 4.0). Serious injury in the previous 12 months was reported by 29.00% of the students. PTSD was present in 15.67% (men 15.39% and women 16.1%). Out of the total, 41.33% of the students had depressive symptoms (35.71% mild–moderate symptoms and 5.62% severe). In the multivariable logistic regression being poor, binge drinking, tobacco use, ever been diagnosed with HIV, physically abused as a child, high PTSD score, and depression (adjusted odds ratio 5.49, 95% confidence interval 4.32–13.21) were significantly (p value < 5%) associated with injury in the last 12 months. Conclusion Unintentional injuries and PTSD symptoms are common in this student population and are positively linked to depression and other risky behaviors. Measures aimed at improving the mental health, such as early identification and treatment of depression, may be useful in reducing the prevalence of such injuries among the youth.","PeriodicalId":22510,"journal":{"name":"The International Journal of Psychiatry in Medicine","volume":"50 1","pages":"299 - 316"},"PeriodicalIF":0.0,"publicationDate":"2015-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84937573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
See Olisah, V. Obiajulu, J. Pérez, A. I. García, Duddu, Venu, S. Husain, Muhammad Ishrat
ACIERNO, RON: See Hernandez-Tejada, Melba A., jt. author ADAMS, DANIEL A.: Case Report: Transient Left Bundle Branch Block Associated with ECT, No. 2, p. 147 ADEKEYE, OLUWATOSIN: See Olisah, Victor Obiajulu, jt. author AHLE, GABRIELLA M.: See Adams, Daniel A., jt. author AICHBERGER, MARION: See Marthoenis, M., jt. author AKENA, DICKENS: See Wagner, Glenn J., jt. author ALOYSI, AMY S.: See Adams, Daniel A., jt. author ASCHBRENNER, KELLY A.: A Mixed Methods Exploration of Family Involvement in Medical Care for Older Adults with Serious Mental Illness, No. 2, p. 121 ATMACA, MURAD: Neurochemical Alterations Associated with Borderline Personality Disorder, No. 4, p. 317 AUNON, FRANCES: See Wagner, Glenn J., jt. author AVERYT, JENNIFER: See de Groot, Mary, jt. author BALATSOURAS, DIMITRIOS: See Katotomichelakis, Michael, jt. author BARTELS, STEPHEN J.: See Aschbrenner, Kelly A., jt. author BRYSON, ETHAN O.: See Adams, Daniel A., jt. author CARROZZINO, R.: See Zuccoli, M. L., jt. author CARTER, CAMERON S.: See Xiong, Glen L., jt. author CHAUDHRY, NASIM: See Husain, Muhammad Ishrat, jt. author DANIELIDES, GERASIMOS: See Katotomichelakis, Michael, jt. author DANIELIDES, VASSILIOS: See Katotomichelakis, Michael, jt. author DAPUETO, JUAN J.: See Pérez, Ana Isabel García, jt. author DAVIDSON, TATIANA M.: Feasibility Assessment of a Brief, Web-Based Behavioral Activation Intervention for Adolescents with Depressed Mood, No. 1, p. 69 DAVIS, AMELIA A.: See Shapiro, Michael, jt. author DE GROOT, MARY: Depressive Sumptoms and Type 2 Diabetes Mellitus in Rural Appalachia: An 18-Month Follow-Up Study, No. 4, p. 263
罗恩·阿齐尔诺:见赫尔南德斯·特哈达，梅尔巴·A·j。作者ADAMS, DANIEL A.:病例报告:瞬变左束分支阻滞与ECT, No. 2, p. 147 ADEKEYE, OLUWATOSIN:参见Olisah, Victor Obiajulu, jt。作者AHLE, GABRIELLA M:见Adams, Daniel A, jt。作者艾希伯格，马里昂:见马索尼斯，M.， j .。作者AKENA，狄更斯:参见Wagner, Glenn J.， jt。作者ALOYSI, AMY S.:参见Adams, Daniel A.， jt。作者ASCHBRENNER, KELLY A.:家庭参与老年严重精神疾病医疗护理的混合方法探索，第2期，第121页，ATMACA, MURAD:与边缘型人格障碍相关的神经化学改变，第4期，第317页，AUNON, FRANCES:参见Wagner, Glenn J.， jt。珍妮弗:见德格鲁特，玛丽，jt。作者BALATSOURAS, DIMITRIOS:参见Katotomichelakis, Michael, jt。作者巴特尔斯:见阿什布伦纳，凯利A, jt。作者布赖森，伊森O:见亚当斯，丹尼尔A, jt。作者CARROZZINO r.r:参见Zuccoli, m.l.， jt。作者卡特，卡梅隆·S:见熊，格伦·L·j·j。作者乔杜里，NASIM:见Husain, Muhammad Ishrat, jt。作者DANIELIDES, GERASIMOS:参见Katotomichelakis, Michael, jt。作者DANIELIDES, VASSILIOS:见Katotomichelakis, Michael, jt。作者DAPUETO, JUAN J.:见psamurez, Ana Isabel García, jt。作者DAVIDSON, TATIANA M:一个简短的，基于网络的行为激活干预青少年抑郁情绪的可行性评估，第1期，第69页。作者DE GROOT, MARY:阿巴拉契亚农村地区的抑郁症状和2型糖尿病:一项18个月的随访研究，第4期，263页
{"title":"The International Journal of PSYCHIATRY IN MEDICINE Index—Contents of Volume 48, 2014","authors":"See Olisah, V. Obiajulu, J. Pérez, A. I. García, Duddu, Venu, S. Husain, Muhammad Ishrat","doi":"10.2190/pm.48.4.h","DOIUrl":"https://doi.org/10.2190/pm.48.4.h","url":null,"abstract":"ACIERNO, RON: See Hernandez-Tejada, Melba A., jt. author ADAMS, DANIEL A.: Case Report: Transient Left Bundle Branch Block Associated with ECT, No. 2, p. 147 ADEKEYE, OLUWATOSIN: See Olisah, Victor Obiajulu, jt. author AHLE, GABRIELLA M.: See Adams, Daniel A., jt. author AICHBERGER, MARION: See Marthoenis, M., jt. author AKENA, DICKENS: See Wagner, Glenn J., jt. author ALOYSI, AMY S.: See Adams, Daniel A., jt. author ASCHBRENNER, KELLY A.: A Mixed Methods Exploration of Family Involvement in Medical Care for Older Adults with Serious Mental Illness, No. 2, p. 121 ATMACA, MURAD: Neurochemical Alterations Associated with Borderline Personality Disorder, No. 4, p. 317 AUNON, FRANCES: See Wagner, Glenn J., jt. author AVERYT, JENNIFER: See de Groot, Mary, jt. author BALATSOURAS, DIMITRIOS: See Katotomichelakis, Michael, jt. author BARTELS, STEPHEN J.: See Aschbrenner, Kelly A., jt. author BRYSON, ETHAN O.: See Adams, Daniel A., jt. author CARROZZINO, R.: See Zuccoli, M. L., jt. author CARTER, CAMERON S.: See Xiong, Glen L., jt. author CHAUDHRY, NASIM: See Husain, Muhammad Ishrat, jt. author DANIELIDES, GERASIMOS: See Katotomichelakis, Michael, jt. author DANIELIDES, VASSILIOS: See Katotomichelakis, Michael, jt. author DAPUETO, JUAN J.: See Pérez, Ana Isabel García, jt. author DAVIDSON, TATIANA M.: Feasibility Assessment of a Brief, Web-Based Behavioral Activation Intervention for Adolescents with Depressed Mood, No. 1, p. 69 DAVIS, AMELIA A.: See Shapiro, Michael, jt. author DE GROOT, MARY: Depressive Sumptoms and Type 2 Diabetes Mellitus in Rural Appalachia: An 18-Month Follow-Up Study, No. 4, p. 263","PeriodicalId":22510,"journal":{"name":"The International Journal of Psychiatry in Medicine","volume":"1 1","pages":"333 - 336"},"PeriodicalIF":0.0,"publicationDate":"2014-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81258137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ayman See Ozkayar, Lekisha Y. Edwards, See Edwards
AARTS, FLOOR: Coping Style as a Mediator between Attachment and Mental and Physical Health in Patients Suffering from Morbid Obesity, No. 1, p. 75 ABUDALAL, AYMAN: See Ozkayar, Nihal, jt. author ACHERMAN, YAIR: See Aarts, Floor, jt. author AKBAS, SEHER: See Say, Gök e N., jt. author ALESII, LEKISHA Y. EDWARDS: See Edwards, Christopher L., jt. author ALTINDAL, MAHMUT: See Ozkayar, Nihal, jt. author ALTUN, BULENT: See Ozkayar, Nihal, jt. author ARICI, MUSTAFA: See Ozkayar, Nihal, jt. author BARKER, CAMELA S.: See Edwards, Christopher L., jt. author BILGI , AYHAN: See Kömürc , Erkam, jt. author BLACKMAN, KAREN S.: Self-Report Tool for Recognizing Mania (SToRM): A New Scale for Aiding in the Diagnosis of Bipolar Disorder, No. 3, p. 193 BORCKARDT, JEFFERY J.: See Edwards-Hampton, Shenelle A., jt. author BRANDJES, DEES P. M.: See Aarts, Floor, jt. author BROCK, CLIVE D.: See Johnson, Alan H., jt. author BUTTERIS, REGINA: See Koc, Feyza, jt. author BYRD, GOLDIE S.: See Edwards, Christopher L., jt. author BYRNE, KARL T.: See Edwards-Hampton, Shenelle A., jt. author CARLTON, JANICE C.: See Stern, Patricia J., jt. author CHUNG, KUO-HSUAN: See Tang, Han-Ching, jt. author CIOLETTI, ANNE: See Lieberman, Daniel Z., jt. author COGDILL, BRITTANY R.: Evaluation of Urinalyses Ordered for Diagnosis of Urinary Tract Infections at an Inpatient Psychiatric Hospital, No. 1, p. 17 COLLANTES, ROCHELLE S.: See Lieberman, Daniel Z., jt. author COLLINS-MCNEIL, JANICE: See Edwards, Christopher L., jt. author CROWLEY, NINA: See Edwards-Hampton, Shenelle A., jt. author DECASTRO, LAURA: See Edwards, Christopher L., jt. author
《应对方式对病态肥胖患者心理和生理健康的影响》，第1期，第75页。作者艾克曼，YAIR:参见艺术，地板，jt。作者AKBAS, SEHER: See Say, Gök e N.， jt。作者ALESII, LEKISHA Y. EDWARDS:参见EDWARDS, Christopher L.， jt。作者ALTINDAL, MAHMUT:见Ozkayar, Nihal, jt。作者ALTUN, BULENT:见Ozkayar, Nihal, jt。作者ARICI, MUSTAFA:见Ozkayar, Nihal, jt。作者卡米拉·巴克:见爱德华，克里斯托弗·L.， jt。作者BILGI, AYHAN:参见Kömürc, Erkam, jt。作者布莱克曼:《识别狂躁的自我报告工具(风暴):帮助诊断双相情感障碍的新量表》，第3期，第193页。作者BRANDJES, des p.m.:参见艺术，地板，jt。克莱夫·D·布罗克:见约翰逊、艾伦·H·j·j。作者巴斯，里贾纳:见Koc, Feyza, jt。作者BYRD, GOLDIE S:参见Edwards, Christopher L.， jt。卡尔·T·伯恩:见爱德华·汉普顿，谢奈尔·A·j·j。作者贾尼斯·卡尔顿:见斯特恩、帕特里夏·J·J·J。作者:钟国轩:See Tang, Han-Ching, jt。作者ANNE CIOLETTI:参见Lieberman, Daniel Z.， jt。作者COGDILL, BRITTANY R.:《精神病院住院患者尿路感染诊断所需尿液分析的评估》，第1期，第17页。作者柯林斯-麦克内尔:见爱德华兹，克里斯托弗·L.， jt。作者克劳利:见爱德华·汉普顿，谢奈尔·A·j·j。作者劳拉·迪卡斯特罗:见爱德华，克里斯托弗·L·j。作者
{"title":"The International Journal of Psychiatry in Medicine Index—Contents of Volume 47, 2014","authors":"Ayman See Ozkayar, Lekisha Y. Edwards, See Edwards","doi":"10.2190/PM.47.4.k","DOIUrl":"https://doi.org/10.2190/PM.47.4.k","url":null,"abstract":"AARTS, FLOOR: Coping Style as a Mediator between Attachment and Mental and Physical Health in Patients Suffering from Morbid Obesity, No. 1, p. 75 ABUDALAL, AYMAN: See Ozkayar, Nihal, jt. author ACHERMAN, YAIR: See Aarts, Floor, jt. author AKBAS, SEHER: See Say, Gök e N., jt. author ALESII, LEKISHA Y. EDWARDS: See Edwards, Christopher L., jt. author ALTINDAL, MAHMUT: See Ozkayar, Nihal, jt. author ALTUN, BULENT: See Ozkayar, Nihal, jt. author ARICI, MUSTAFA: See Ozkayar, Nihal, jt. author BARKER, CAMELA S.: See Edwards, Christopher L., jt. author BILGI , AYHAN: See Kömürc , Erkam, jt. author BLACKMAN, KAREN S.: Self-Report Tool for Recognizing Mania (SToRM): A New Scale for Aiding in the Diagnosis of Bipolar Disorder, No. 3, p. 193 BORCKARDT, JEFFERY J.: See Edwards-Hampton, Shenelle A., jt. author BRANDJES, DEES P. M.: See Aarts, Floor, jt. author BROCK, CLIVE D.: See Johnson, Alan H., jt. author BUTTERIS, REGINA: See Koc, Feyza, jt. author BYRD, GOLDIE S.: See Edwards, Christopher L., jt. author BYRNE, KARL T.: See Edwards-Hampton, Shenelle A., jt. author CARLTON, JANICE C.: See Stern, Patricia J., jt. author CHUNG, KUO-HSUAN: See Tang, Han-Ching, jt. author CIOLETTI, ANNE: See Lieberman, Daniel Z., jt. author COGDILL, BRITTANY R.: Evaluation of Urinalyses Ordered for Diagnosis of Urinary Tract Infections at an Inpatient Psychiatric Hospital, No. 1, p. 17 COLLANTES, ROCHELLE S.: See Lieberman, Daniel Z., jt. author COLLINS-MCNEIL, JANICE: See Edwards, Christopher L., jt. author CROWLEY, NINA: See Edwards-Hampton, Shenelle A., jt. author DECASTRO, LAURA: See Edwards, Christopher L., jt. author","PeriodicalId":22510,"journal":{"name":"The International Journal of Psychiatry in Medicine","volume":"6 1","pages":"369 - 373"},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73587704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Book Review: Clinical Handbook of Psychotropic Drugs","authors":"S. Bragg","doi":"10.2190/PM.47.1.h","DOIUrl":"https://doi.org/10.2190/PM.47.1.h","url":null,"abstract":"","PeriodicalId":22510,"journal":{"name":"The International Journal of Psychiatry in Medicine","volume":"41 1","pages":"93 - 95"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87033209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：